0

0

0

Jump to Topics

IIT Madras creates AI tool to identify glioblastoma

IIT Madras creates AI tool to identify glioblastoma

AI is revolutionising the healthcare domain, and a team from IIT Madras has harnessed this technology to develop a machine learning-based tool to detect a type of brain cancer called glioblastoma
IIT Madras team has harnessed AI technology to to detect a type of brain cancer called glioblastomas
IIT Madras team has harnessed AI technology to detect glioblastomas | Representational Image: Shutterstock

Researchers from the Indian Institute of Technology Madras (IITM) have developed a tool based on machine learning to detect a type of brain cancer called glioblastoma multiforme (GBM).

The researchers say that their device, named GBMDriver, is publicly available online and could revolutionise the detection of brain and spinal cord cancers.

The study results are published in Briefings in Bioinformatics.

Studies show that glioblastomas originate in the brain and spine. Some gene mutations lead to uncontrolled cell division and aberrant signalling pathways, causing cancer. Detection of brain cancer, specifically glioblastomas, can be challenging, mainly due to non-specific symptoms like headaches, personality changes, nausea, and stroke. Despite extensive research, this condition has limited therapeutic options, and the survival rate is currently low.

Drivers and passengers

Developing the right treatment strategy for glioblastoma requires a deep understanding of how protein mutations affect brain cancer. But it is hard to identify which mutations cause this condition.

Driver and passenger mutations are the two frequently occurring mutations in our body,” Prof Michael Gromiha from the Department of Biotechnology at IITM tells Happiest Health. Driver mutations give cancer cells the advantage of uncontrolled growth. In contrast, he explains, passenger mutations occur during cell division and do not contribute to causing cancer.

“Firstly, to better understand GBM, we need to understand the particular protein sequences and their characteristics responsible for cancerous and non-cancerous activity,” he says. After identifying these protein sequences, they deliver the data into machine learning algorithms for analysis.

Machine learning relies on extensive data and algorithms to give precise outcomes. “Machine learning algorithms enable computers to learn and improve their performance over time as they are exposed to more data,” says Dr Vivek Ruhela, a researcher at Indraprastha Institute of Information Technology (IIIT), New Delhi.

Read more : Know the brain regions

Read more: Aiming nanodrugs at brain cancer in children

A dive into GBMDriver

The IIT team extracted clinical data from COSMIC and OncoKB databases for driver mutations to develop the tool. They also retrieved passenger mutations from different databases that serve as a control group.

Using these databases, researchers made a dataset that contains 9,386 driver and 8,728 passenger mutations. They based it on the reoccurrence of cancer-causing mutations in every 3 GBM-affected people.

To develop this tool, Prof Gromiha explains they considered various factors, such as the properties and patterns of amino acids and protein formation. In addition, they employed algorithms to segregate driver and passenger mutation in the database of GBM-affected people.

To check the accuracy of GBMDriver, they tested the tool on clinical data of 1,809 randomly chosen GBM-affected people. “This tool achieved an accuracy of 81.99 per cent in identifying driver mutations. The detection results from this tool are better than the current diagnostic methods for this condition,” says Dr Gromiha.

The researchers state that the success of GBMDriver could be a game-changer in treating brain cancer. “However, if we have a high number of data, then we can improve the GBMDriver model with more detailed and specific features,” he adds.

Dr Ruhela agrees that AI algorithms can be trained to identify patterns and predict the likelihood of developing certain diseases or conditions from large data sets. “This can enable healthcare professionals to intervene early and provide preventive care to high-risk patients,” he says.

Share Your Experience/Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Articles

Video
CPR or cardiopulmonary resuscitation is an emergency lifesaving procedure performed when the heart stops beating. According to American Heart Association, immediate CPR can double or triple chances of survival after cardiac arrest. Keeping the blood flow active, even partially, extends the opportunity for a successful resuscitation once trained medical staff arrive on site. It is an important lifesaving first-aid tool that can be performed by anyone.
Article
A new lifestyle adaptation seems to be about breaking a set of habits that are not as innocuous as they are believed to be
Video
Chocolates have been credited for providing better heart health. According to a study published in the European Journal of Preventive Cardiology in 2020, eating chocolate at least once a week helps reduce the risk of heart disease. The study says that eating chocolate more than once a week was associated with an eight per cent decreased risk of coronary artery disease. But how does one choose a good dark chocolate? Watch to find out.
Article
People with vitamin D deficiency have a lower insulin secretion than those with optimal levels of the vitamin, according to some studies
Previous
Next

0

0

0

Opt-in To Our Daily Newsletter

* Please check your Spam folder for the Opt-in confirmation mail
We use cookies to customize your user experience, view our policy here

Your feedback has been submitted successfully.

The Happiest Health team will reach out to you at the earliest